Heart failure affects 4% of the US population, yet treatment options are primarily symptomatic, including blood thinners, assistive devices and heart transplant. Patients today face a 50% 5-year survival rate upon diagnosis. It’s time to change that. Our approach is to engineer human cardiac organoids that function similarly to adult human heart tissue, enabling us to directly target therapeutics to the heart. We aim to address the root cause of heart failure and restore heart function.
| Website | http://www.dynomics.com |
| Employees | 7 (2 on RocketReach) |
| Founded | 2020 |
| Industry | Biotechnology Research, Therapeutic Devices |
| Keywords | Heart Failure Treatment, Therapeutic Solutions, Cardiovascular Disease, Health Improvement, Cardiology, Innovation, Health Outcomes, Patient Care, Precision Medicine, Medical Devices, Medical Research, Patient Monitoring, Healthcare Technology, Digital Health, Health Tech, Clinical Trials, Remote Patient Monitoring, Biomedical Engineering, Drug Discovery, Assistive Technology |
| Competitors | Microsoft, IBM, Salesforce, SAS, DataRobot, Dataiku, Alteryx, Tableau, Qlik, Altair RapidMiner +37 more (view full list) |
Looking for a particular Dynomics employee's phone or email?
Dynomics Questions
Drew Titmarsh is the CEO and Co-founder of Dynomics.
2 people are employed at Dynomics.
Dynomics is based in San Francisco, California.
Top Dynomics Employees
-
Drew Titmarsh
CEO and Co-founder at Dynomics
San Francisco, CA, US24 -
Suha Jhaveri
Board Member at Dynomics
San Francisco, CA, US35+
Related Companies
